Table 1 Patient characteristics, study methodology, and quality assessment of included trials
Author, year | Patient Diagnosis | Surgery | Study Design | Enrolled sample number (Male/Female) | Average age, years | Intention-to-treat | Outcome measurement | Quality assessment |
|---|---|---|---|---|---|---|---|---|
Ruixiang Zhang et.al, 2014 [1] | Esophageal cancer | MIE | Case-Control | DLET:60/21 SLET:34/8 | DLET:64.3 ± 6.5 SLET:62.5 ± 6.5 | Not mentioned | Surgical variables and postoperative complications | 8 |
Itasu Ninomiya et.al, 2017 [15] | Esophageal cancer | MIE | Case-Control | DLET:49/9 SLET:28/9 | DLET: 65.8 ± 8.5 SLET:63.1 ± 8.2 | Not mentioned | Postoperative mortality and morbidity rates; Surgical outcomes during thoracic procedures | 8 |
Miao Lin et.al, 2018 [16] | Esophageal cancer | MIE | Case-Control | DLET:527/178 SLET:359/102 | DLET:61.8 ± 7.89 SLET:61.4 ± 7.92 | Not mentioned | Surgical variables and postoperative complications; Parameters during surgery | 8 |
Shinsuke Nomura et.al, 2020 [17] | Esophageal cancer | MIE | Case-Control | DLET:59/12 SLET:41/7 | DLET:71.1 ± 5.8 SLET:69.9 ± 10.1 | Not mentioned | Comparison of postoperative outcomes; Perioperative changes in SIRS criteria, PaO2/FiO2 ratio and CRP | 8 |